26-May-2026
Download PDF
Vanta Bioscience
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the half year and the financial year ended March 31 2026 and to take note of the Audit Reports issued by the Statutory Auditors thereon
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
